Cargando…
Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges
The sudden rise of the worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in early 2020 has called into drastic action measures to perform instant detection and reduce the rate of spread. Common clinical and nonclinical diagnostic testing methods have been partially effe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AIP Publishing LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427516/ https://www.ncbi.nlm.nih.gov/pubmed/34552683 http://dx.doi.org/10.1063/5.0022211 |
_version_ | 1783750189096370176 |
---|---|
author | Asghari, Aref Wang, Chao Yoo, Kyoung Min Rostamian, Ali Xu, Xiaochuan Shin, Jong-Dug Dalir, Hamed Chen, Ray T. |
author_facet | Asghari, Aref Wang, Chao Yoo, Kyoung Min Rostamian, Ali Xu, Xiaochuan Shin, Jong-Dug Dalir, Hamed Chen, Ray T. |
author_sort | Asghari, Aref |
collection | PubMed |
description | The sudden rise of the worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in early 2020 has called into drastic action measures to perform instant detection and reduce the rate of spread. Common clinical and nonclinical diagnostic testing methods have been partially effective in satisfying the increasing demand for fast detection point-of-care (POC) methods to slow down further spread. However, accurate point-of-risk diagnosis of this emerging viral infection is paramount as the need for simultaneous standard operating procedures and symptom management of SARS-CoV-2 will be the norm for years to come. A sensitive, cost-effective biosensor with mass production capability is crucial until a universal vaccination becomes available. Optical biosensors can provide a noninvasive, extremely sensitive rapid detection platform with sensitivity down to ∼67 fg/ml (1 fM) concentration in a few minutes. These biosensors can be manufactured on a mass scale (millions) to detect the COVID-19 viral load in nasal, saliva, urine, and serological samples, even if the infected person is asymptotic. Methods investigated here are the most advanced available platforms for biosensing optical devices that have resulted from the integration of state-of-the-art designs and materials. These approaches include, but are not limited to, integrated optical devices, plasmonic resonance, and emerging nanomaterial biosensors. The lab-on-chip platforms examined here are suitable not only for SARS-CoV-2 spike protein detection but also for other contagious virions such as influenza and Middle East respiratory syndrome (MERS). |
format | Online Article Text |
id | pubmed-8427516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AIP Publishing LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-84275162021-09-20 Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges Asghari, Aref Wang, Chao Yoo, Kyoung Min Rostamian, Ali Xu, Xiaochuan Shin, Jong-Dug Dalir, Hamed Chen, Ray T. Appl Phys Rev Reviews The sudden rise of the worldwide severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in early 2020 has called into drastic action measures to perform instant detection and reduce the rate of spread. Common clinical and nonclinical diagnostic testing methods have been partially effective in satisfying the increasing demand for fast detection point-of-care (POC) methods to slow down further spread. However, accurate point-of-risk diagnosis of this emerging viral infection is paramount as the need for simultaneous standard operating procedures and symptom management of SARS-CoV-2 will be the norm for years to come. A sensitive, cost-effective biosensor with mass production capability is crucial until a universal vaccination becomes available. Optical biosensors can provide a noninvasive, extremely sensitive rapid detection platform with sensitivity down to ∼67 fg/ml (1 fM) concentration in a few minutes. These biosensors can be manufactured on a mass scale (millions) to detect the COVID-19 viral load in nasal, saliva, urine, and serological samples, even if the infected person is asymptotic. Methods investigated here are the most advanced available platforms for biosensing optical devices that have resulted from the integration of state-of-the-art designs and materials. These approaches include, but are not limited to, integrated optical devices, plasmonic resonance, and emerging nanomaterial biosensors. The lab-on-chip platforms examined here are suitable not only for SARS-CoV-2 spike protein detection but also for other contagious virions such as influenza and Middle East respiratory syndrome (MERS). AIP Publishing LLC 2021-09 /pmc/articles/PMC8427516/ /pubmed/34552683 http://dx.doi.org/10.1063/5.0022211 Text en © 2021 Author(s). https://creativecommons.org/licenses/by/4.0/All article content, except where otherwise noted, is licensed under a Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Reviews Asghari, Aref Wang, Chao Yoo, Kyoung Min Rostamian, Ali Xu, Xiaochuan Shin, Jong-Dug Dalir, Hamed Chen, Ray T. Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges |
title | Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges |
title_full | Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges |
title_fullStr | Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges |
title_full_unstemmed | Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges |
title_short | Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges |
title_sort | fast, accurate, point-of-care covid-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: opportunities and challenges |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427516/ https://www.ncbi.nlm.nih.gov/pubmed/34552683 http://dx.doi.org/10.1063/5.0022211 |
work_keys_str_mv | AT asghariaref fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges AT wangchao fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges AT yookyoungmin fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges AT rostamianali fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges AT xuxiaochuan fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges AT shinjongdug fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges AT dalirhamed fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges AT chenrayt fastaccuratepointofcarecovid19pandemicdiagnosisenabledthroughadvancedlabonchipopticalbiosensorsopportunitiesandchallenges |